Search Results - "YEE KIT TSE"
-
1
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
Published in Hepatology (Baltimore, Md.) (01-08-2022)“…Background and Aims Angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can inhibit liver fibrogenesis in animal models…”
Get full text
Journal Article -
2
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19
Published in Gut (01-04-2021)“…Data on serial liver biochemistries of patients infected by different human coronaviruses (HCoVs) are lacking. The impact of liver injury on adverse clinical…”
Get more information
Journal Article -
3
An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017
Published in Hepatology (Baltimore, Md.) (01-02-2020)“…Patients with chronic hepatitis B (CHB) are aging because of improved survival under better health care. This has an important implication on the choice of…”
Get full text
Journal Article -
4
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19
Published in Hepatology (Baltimore, Md.) (01-10-2021)“…Background and Aims We compared risk of acute liver injury and mortality in patients with COVID‐19 and current, past, and no HBV infection. Approach and…”
Get full text
Journal Article -
5
Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
Published in Liver international (01-03-2020)“…Background and aims In non‐alcoholic fatty liver disease (NAFLD), fibrosis is the strongest prognostic factor and can be assessed by non‐invasive methods. We…”
Get full text
Journal Article -
6
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
Published in Hepatology (Baltimore, Md.) (01-11-2022)“…Background and Aims Several guidelines recommend screening for NAFLD in patients with type 2 diabetes (T2D). We aimed to determine if there is a threshold of…”
Get full text
Journal Article -
7
Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness
Published in Hepatology (Baltimore, Md.) (01-09-2019)“…We previously demonstrated the possible noninferiority of a screening strategy for varices guided by liver and spleen stiffness measurement (LSSM) compared to…”
Get full text
Journal Article -
8
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease
Published in Hepatology (Baltimore, Md.) (01-02-2023)“…It is unclear if the leading causes of death in patients with NAFLD differ by age. We aimed to investigate if the relative importance of liver-related deaths…”
Get full text
Journal Article -
9
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment
Published in Alimentary pharmacology & therapeutics (01-11-2018)“…Summary Background In clinical trials involving patients with preserved renal function, tenofovir disoproxil fumarate (TDF) use was associated with mild renal…”
Get full text
Journal Article -
10
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
Published in Journal of gastroenterology (01-09-2020)“…Background Hepatitis B core-related antigen (HBcrAg) is a novel serum viral marker. Recent studies showed that its level correlates with the risk of…”
Get full text
Journal Article -
11
Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection
Published in The American journal of gastroenterology (01-06-2021)“…Immunotherapy has dramatically improved the survival of patients with advanced or metastatic malignancies. Recent studies suggest that immunotherapy may…”
Get full text
Journal Article -
12
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss
Published in Alimentary pharmacology & therapeutics (01-01-2021)“…Summary Background It is unknown whether patients with chronic hepatitis B (CHB) who achieved hepatitis B surface antigen (HBsAg) seroclearance spontaneously…”
Get full text
Journal Article -
13
Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
Published in The American journal of gastroenterology (01-12-2017)“…Liver stiffness measurement (LSM) by transient elastography (TE) has been shown to predict outcomes in patients with liver disease. While controlled…”
Get full text
Journal Article -
14
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
Published in Journal of hepatology (01-11-2015)“…Graphical abstract…”
Get full text
Journal Article -
15
Machine learning model to predict recurrent ulcer bleeding in patients with history of idiopathic gastroduodenal ulcer bleeding
Published in Alimentary pharmacology & therapeutics (01-04-2019)“…Summary Background Patients with a history of Helicobacter pylori–negative idiopathic bleeding ulcers have an increased risk of recurring ulcer complications…”
Get full text
Journal Article -
16
Long‐term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects
Published in Hepatology (Baltimore, Md.) (01-09-2015)“…Widespread and long‐term use of oral nucleos(t)ide analogs (NAs) to treat chronic hepatitis B (CHB) brings about safety data in a real‐life setting. We aimed…”
Get full text
Journal Article -
17
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
Published in Alimentary pharmacology & therapeutics (01-09-2022)“…Summary Background Universal vaccination of newborns with hepatitis B virus (HBV) vaccine is the most important strategy to prevent chronic HBV infection and…”
Get full text
Journal Article -
18
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection
Published in Alimentary pharmacology & therapeutics (01-10-2023)“…It is uncertain whether people with HIV infection have a higher incidence of hepatocellular carcinoma (HCC) than the general population. To compare the…”
Get full text
Journal Article -
19
Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study
Published in Clinical infectious diseases (18-05-2021)“…The case-fatality ratios (CFR) of coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) appeared to differ substantially. We aimed…”
Get full text
Journal Article -
20
On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
Published in Hepatology (Baltimore, Md.) (01-03-2014)“…Alpha‐fetoprotein (AFP) is the most widely used biomarker for hepatocellular carcinoma (HCC) surveillance, which is criticized as neither sensitive nor…”
Get full text
Journal Article